Vorträge und Veranstaltungen

IGES-Expertinnen und -Experten sind gefragte Referenten auf Kongressen, Konferenzen oder Tagungen und unterstützen den bestehenden Diskurs zu aktuellen Fragestellungen des Gesundheitswesens und der Gesundheitsversorgung.

Zudem initiiert oder organisiert das IGES Institut seit vielen Jahren wissenschaftliche Fachveranstaltungen, oft auch in Zusammenarbeit mit Kunden oder Projektpartnern.

Mit dem Auditorium Friedrichstraße verfügt das IGES Institut für Veranstaltungen über ein hauseigenes Kongresszentrum im Zentrum von Berlin.

04.11.25

-

Podiumsdiskussion

Dr. Tilo Mandry

-

Panel Discussion: How to enter Europe and strike the right chord for market success

14.30 - 15.15 Uhr

-

Merken

 (Outlook)
 (iCal)

Exhibit Hall Stage

Wien

Veranstaltungssprache: Englisch

Veranstaltung: BIO-Europe 2025

Konferenz

Biopharmaceutical companies with products in late-stage clinical development often encounter significant challenges when entering the European market. While the European Union offers a unified market authorization procedure, market access and reimbursement remain under the jurisdiction of individual member states—a situation unlikely to change in the near future. The harmonization of health technology assessments (HTA), which began rolling out in early 2025, focuses solely on clinical evaluations, leaving pricing decisions to be made independently by each country. Additionally, navigating the complex system of price referencing between European nations presents another layer of difficulty. Despite these obstacles, Europe has seen the successful launch of innovative therapies, particularly in rare diseases. This session will leverage case studies to explore key considerations for companies not yet established in Europe. It will provide insights into how to achieve successful market entry, address the challenges of the price referencing system, and evaluate the value of a therapy in the European context—whether for licensing or direct commercialization. Attendees will gain practical strategies for overcoming hurdles and tapping into the opportunities within the European biopharma market. Further panelists: - Pierre Emanuel Puig | Ultragenyx - Diana Sinkevich | Chiesi Group -Janneke van der Kamp | Norgine

  Informationen zur Veranstaltung